Webinars
-
LIVE SUMMIT – Nov 19-25, 2024
Dr.Talks Prostate Cancer Summit – Register for Free Today!
Learn from leading experts about prostate cancer screening and insights throughout this five day seminar exploring all facets of prostate health. On day 2, Dr. Punnen will explore the utility of biomarkers and MRI and their usefulness in detecting cancer.
-
Preventing Prostate Biopsies: Urine Exosome Innovations with Dr. Johan Skog
Explore the groundbreaking science, clinical implications, and crucial role exosomes play in the ExoDx Prostate Test with Dr. Johan Skog as he interviews with Dr. Geo on this episode of The Dr. Geo Podcast. -
Revolutionizing Prostate Cancer Diagnosis: Urine Testing Insights with Dr. David Albala
Join Dr. Geo in his interview with Dr. David Albala, Chief of Urology at Crouse Hospital and an expert in laparoscopic and robotic urological surgery, as they explore the advancements in prostate cancer diagnosis. -
An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis
Prostate cancer guidelines seek to optimize diagnosis while minimizing over-diagnosis. This webinar explores integrating biomarkers like ExoDx Prostate Test with MRI imaging for better risk assessment in patients considering biopsy. -
New Technologies for Prostate Screening
In this episode of BackTable Urology, Dr. Jose Silva interviews Dr. Ali Kasraeian, a private practice urologic oncologist in Jacksonville, about different techniques and research on prostate cancer screenings. -
Prostate Cancer Diagnosis Made Easier: Urine Tests Explained by Dr. Jason Alter
Dr. Geo interviewed Dr. Jason Alter, the Head of Scientific Affairs at Exosome Diagnostics, regarding the effectiveness of urine tests for identifying prostate cancer. -
Simple Non-Invasive Urine Test for Prostate Cancer Risk | Part 3 of 3
Part 3 of 3. Dr. Phranq Tamburri, N.M.D., presents on what makes the ExoDx Prostate Test unique as well as why liquid biomarkers are useful. -
Simple Non-Invasive Urine Test for Prostate Cancer Risk | Part 2 of 3
Part 2 of 3. Dr. Phranq Tamburri, N.M.D., explains more about PSA (Prostate Specific Antigen) and three factors in assessing prostate cancer. -
Simple Non-Invasive Urine Test for Prostate Cancer Risk | Part 1 of 3
Dr. Phranq Tamburri, N.M.D., presents on pandemic-induced changes in prostate cancer screening, the significance of PSA assessment amidst evolving guidelines, and the benefits of analyzing 3 genes in the ExoDx Prostate Test. -
BIO-TECHNE ANNOUNCES PUBLICATION OF NEW DATA DEMONSTRATING EXODX PROSTATE TEST CORRELATION WITH POST-PROSTATECTOMY PATHOLOGY OUTCOMES
Dr. Alexander Kretschmer, and colleagues demonstrated utility of the ExoDx™ Prostate test, to address limitations related to prostate biopsy sampling error, prostate biopsy bias as well as multifocality of of the disease, providing a more relevant assessment of low-risk men who could remain on AS.